Is there a different chain where we can compare similar MCap pharma companies? How do these 4 companies stack up in terms of revenue growth, margin expansion in next few years? I have given some data below – no one stands out on all parameters
Mcap | PE | Annual Sales 2022-23 | Net Profit 22-23 | OPM | |
---|---|---|---|---|---|
Caplin Point | 9036 | 21.67 | 467 | 377 | 30% |
Marksans Pharma | 7261 | 24.5 | 1852 | 265 | 18% |
Glenmark Life Sciences | 7791 | 15.4 | 2161 | 467 | 30% |
Neuland Labs | 6580 | 24.7 | 1191 | 164 | 23% |
Regards,
Abhinav
Subscribe To Our Free Newsletter |